Infectious diseases pharmacy practice, education, and research in Saudi Arabia: A review and future perspectives by the Infectious Diseases Pharmacy Specialty Network at the Saudi Society of Clinical Pharmacy.
Autor: | Alsowaida YS; Department of Clinical Pharmacy, College of Pharmacy, Hail University, P.O. Box 6166, Hail 81442, Saudi Arabia.; Division of Infectious Diseases, the Warren Alpert Medical School, Brown University, Providence, RI 02903, USA., Thabit AK; Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Almangour TA; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia., Bin Saleh K; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, P.O. Box 3660, Riyadh 11481, Saudi Arabia.; King Abdullah International Medical Research Center, P.O. Box 3660, Riyadh 11481, Saudi Arabia.; Pharmaceutical Care Department, King Abdulaziz Medical City, P.O. Box 3660, Riyadh 11481, Saudi Arabia., Mahrous A; Department of Clinical Pharmacy, College of Pharmacy, Umm Al Qura University, Makkah, Saudi Arabia., Saeed Almutairi M; Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia., Alshehail B; Pharmacy Practice Department, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia., Aljefri D; Department of Pharmacy, King Abdulaziz Medical City, Jeddah, Saudi Arabia., Mohzari Y; Pharmaceutical Care Division, King Saud Medical City, Riyadh, Saudi Arabia., Alfahad W; Department of Pharmacy Services, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Almohaizeie A; Pharmaceutical care division, King Faisal Specialist Hospital and Research Center and, Faculty of Pharmacy and Medicine, Alfaisal University, Riyadh, Saudi Arabia., Eljaaly K; Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2022 Dec; Vol. 30 (12), pp. 1836-1843. Date of Electronic Publication: 2022 Nov 03. |
DOI: | 10.1016/j.jsps.2022.10.014 |
Abstrakt: | Background: Infectious diseases (ID) pharmacy is one of the rapidly evolving clinical pharmacy specialties in the Kingdom of Saudi Arabia (KSA). There are gaps in the literature on ID pharmacy status in KSA. This review aimed to provide an update on the current status of several areas related to ID pharmacy in KSA, including practice, education, and research, and make pertinent recommendations for future development to achieve the KSA Vision, 2030, KSA Vision, 2030. Methods: This review was developed by a group of ID pharmacists working in different sectors under the umbrella of the ID Pharmacy Specialty Network (PSN) of the Saudi Society of Clinical Pharmacy (SSCP). The authors evaluated domains related to ID pharmacy in KSA and searched the literature for relevant articles. Based on the experts' assessment of the current gaps and challenges, recommendations were made for future improvement. Results: Several aspects of ID pharmacy in KSA were evaluated, including history and development, antimicrobial resistance (AMR), antimicrobial stewardship programs (ASP), roles of ID pharmacists, ID pharmacy education, and research. The biggest challenges include AMR, the varying levels of ASP implementation, and the low number of ID-trained pharmacists, especially in non-major cities. Several recommendations for improvement were discussed. Conclusion: Infectious diseases pharmacy has sustained remarkable progress in KSA in several areas. However, more efforts are needed to increase ASP implementation, increase the number of ID-trained pharmacists, and encourage ID pharmacists in publishing and participating in practice guidelines, which will eventually help achieve the KSA Vision, 2030, KSA Vision, 2030. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2022 The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |